Peacock Karen bought IDXX
December 1, 2025 · Form 4 insider transaction
Peacock Karen bought 231 shares of IDEXX Laboratories, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
231
Price
$0.00
Total value
N/A
InsiderPeacock Karen
Role—
SecurityNon-Qualified Stock Option (right-to-buy)
Transaction codeA: Grant or award
Transaction dateDecember 1, 2025
Filing dateDecember 3, 2025
Shares owned after231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from the date of her election to the IDEXX Laboratories, Inc. Board of Directors on October 6, 2025 until the 2026 annual meeting of stockholders.; Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.